Correction: Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy
Oncotarget
.
2018 Mar 30;9(24):17256.
doi: 10.18632/oncotarget.25064.
Authors
Giuseppe Gritt
1
,
Andrea Gianatt
2
,
Fiorella Petronzeii
3
,
Rita De Santis
3
,
Chiara Pavoni
1
,
Riccardo Lorenzo Rossi
4
,
Laura Cattaneo
2
,
Luigi Giusto Spagnoli
5
,
Silvia Ferrar
1
,
Andrea Ross
1
,
Anna Maria Barbu
1
,
Alessandro Rambald
1
6
Affiliations
1
Hematology and Bone Marrow Transplant Units, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
2
Pathology Unit, Ospedale Papa Giovanni XXII, Bergamo, Italy.
3
Sigma Tau S.p.A. Biotech Products Rand D, Pomezia, Italy.
4
Bioinformatics, Istituto Nazionale Genetica Molecolare, Milan, Italy.
5
Department of Biomedicine and Prevention, Universita di Roma Tor Vergata, Rome, Italy.
6
Department of Oncology and Oncohematology, Universita degli Studi di Milano, Milan, Italy.
PMID:
29683132
PMCID:
PMC5908322
DOI:
10.18632/oncotarget.25064
Abstract
[This corrects the article DOI: 10.18632/oncotarget.23919.].
Publication types
Published Erratum